Alector, Inc. (ALEC) Financial Statements (2024 and earlier)

Company Profile

Business Address 131 OYSTER POINT BLVD., SUITE 600
SOUTH SAN FRANCISCO, CA 94080
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments630,048669,329712,851758,306808,855868,571
Cash and cash equivalents131,540195,555154,323184,231172,265454,620
Short-term investments498,508473,774558,528574,075636,590413,951
Other undisclosed current assets17,94416,67313,58416,65718,16622,355
Total current assets:647,992686,002726,435774,963827,021890,926
Noncurrent Assets
Operating lease, right-of-use asset26,30227,06627,81128,53029,22629,899
Property, plant and equipment24,28924,99825,52126,28926,03426,228
Restricted cash and investments1,5491,4721,4721,4721,4721,472
Other noncurrent assets8,6058,8046,4095,7845,9195,932
Total noncurrent assets:60,74562,34061,21362,07562,65163,531
TOTAL ASSETS:708,737748,342787,648837,038889,672954,457
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities27,58521,70631,96027,77128,35126,794
Accounts payable4,6673,1264,1894,5464,6466,752
Accrued liabilities22,91818,58027,77123,22523,70520,042
Deferred revenue68,55061,77348,231119,684106,99495,611
Other undisclosed current liabilities36,13515,82113,61813,43414,06420,473
Total current liabilities:132,27099,30093,809160,889149,409142,878
Noncurrent Liabilities
Long-term debt and lease obligation:    36,45537,61538,751
Liabilities, other than long-term debt278,986466,027479,397386,590414,132505,291
Deferred revenue245,343431,079443,370386,357413,899505,133
Other liabilities898898759233233158
Operating lease, liability32,74534,05035,26836,45537,61538,751
Other undisclosed noncurrent liabilities101,175     
Total noncurrent liabilities:380,161466,027479,397423,045451,747544,042
Total liabilities:512,431565,327573,206583,934601,156686,920
Equity
Equity, attributable to parent196,306183,015214,442253,104288,516267,537
Common stock888888
Additional paid in capital821,853810,750798,696787,097775,843762,458
Accumulated other comprehensive loss(1,386)(2,199)(4,575)(6,742)(6,224)(3,935)
Accumulated deficit(624,169)(625,544)(579,687)(527,259)(481,111)(490,994)
Total equity:196,306183,015214,442253,104288,516267,537
TOTAL LIABILITIES AND EQUITY:708,737748,342787,648837,038889,672954,457

Income Statement (P&L) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Revenues56,21416,54914,44014,85279,85124,474
Gross profit:56,21416,54914,44014,85279,85124,474
Operating expenses(59,803)(66,664)(69,878)(62,600)(70,376)(68,597)
Operating income (loss):(3,589)(50,115)(55,438)(47,748)9,475(44,123)
Nonoperating income
(Other Nonoperating income)
6,3575,1593,7312,3331,450264
Income (loss) from continuing operations before income taxes:2,768(44,956)(51,707)(45,415)10,925(43,859)
Income tax expense(1,393)(901)(721)(733)(1,042)(758)
Income (loss) from continuing operations:1,375(45,857)(52,428)(46,148)9,883(44,617)
Income (loss) before gain (loss) on sale of properties:(46,148)9,883(44,617)
Net income (loss) available to common stockholders, diluted:1,375(45,857)(52,428)(46,148)9,883(44,617)

Comprehensive Income ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net income (loss):1,375(45,857)(52,428)(46,148)9,883(44,617)
Comprehensive income (loss):1,375(45,857)(52,428)(46,148)9,883(44,617)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent8132,3762,167(518)(2,289)(2,992)
Comprehensive income (loss), net of tax, attributable to parent:2,188(43,481)(50,261)(46,666)7,594(47,609)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: